Cargando…

Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1–4

Type 2 diabetes (T2D)-associated end-stage kidney disease (ESKD) is a global burden, while the renoprotective effects of metformin remain controversial. In a population-based cohort (2002–2018) including 96,643 patients with T2D observed for 0.7 million person-years, we estimated the risk associatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Aimin, Lau, Eric S. H., Wu, Hongjiang, Ma, Ronald C. W., Kong, Alice P. S., So, Wing Yee, Luk, Andrea O. Y., Fu, Amy W. C., Chan, Juliana C. N., Chow, Elaine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505840/ https://www.ncbi.nlm.nih.gov/pubmed/36145361 http://dx.doi.org/10.3390/ph15091140

Ejemplares similares

Trends in diabetes-related complications in Hong Kong, 2001–2016: a retrospective cohort study
por: Wu, Hongjiang, et al.
Publicado: (2020)

Temporal trends in rates of infection-related hospitalisations in Hong Kong people with and without diabetes, 2001–2016: a retrospective study
por: Luk, Andrea O. Y., et al.
Publicado: (2020)

Trends in kidney failure and kidney replacement therapy in people with diabetes in Hong Kong, 2002-2015: A retrospective cohort study
por: Wu, Hongjiang, et al.
Publicado: (2021)

Age-specific population attributable risk factors for all-cause and cause-specific mortality in type 2 diabetes: An analysis of a 6-year prospective cohort study of over 360,000 people in Hong Kong
por: Wu, Hongjiang, et al.
Publicado: (2023)

Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine
por: Tuot, Delphine S., et al.
Publicado: (2015)

Improved estimation of glomerular filtration rate (GFR) by comparison of eGFR(cystatin C) and eGFR(creatinine)
por: Grubb, Anders, et al.
Publicado: (2012)

Analysis of eGFR index category and annual eGFR slope association with adverse clinical outcomes using real-world Japanese data: a retrospective database study
por: Zhang, Ling, et al.
Publicado: (2022)

Age- and sex-specific hospital bed-day rates in people with and without type 2 diabetes: A territory-wide population-based cohort study of 1.5 million people in Hong Kong
por: Wu, Hongjiang, et al.
Publicado: (2023)

Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study
por: Luk, Andrea O. Y., et al.
Publicado: (2020)

Incident cardiovascular-kidney disease, diabetic ketoacidosis, hypoglycaemia and mortality in adult-onset type 1 diabetes: a population-based retrospective cohort study in Hong Kong
por: Fan, Yingnan, et al.
Publicado: (2023)

Cystacin C-based eGFR and Creatinine Clearance-based eGFR in Patients with Severe Motor and Intellectual Disabilities
por: Tamura, Kouichi, et al.
Publicado: (2023)

Age- and gender-adjusted eGFR to estimate baseline creatinine for RIFLE criteria
por: Spoorenberg, Simone M. C., et al.
Publicado: (2011)

Relative leucocyte telomere length is associated with incident end-stage kidney disease and rapid decline of kidney function in type 2 diabetes: analysis from the Hong Kong Diabetes Register
por: Cheng, Feifei, et al.
Publicado: (2021)

Lifetime risk of developing diabetes in Chinese people with normoglycemia or prediabetes: A modeling study
por: Zhang, Xinge, et al.
Publicado: (2022)

A Clinical Perspective of the Multifaceted Mechanism of Metformin in Diabetes, Infections, Cognitive Dysfunction, and Cancer
por: Chow, Elaine, et al.
Publicado: (2022)

Glucose-lowering drug use, glycemic outcomes, and severe hypoglycemia: 18-Year trends in 0·9 million adults with Diabetes in Hong Kong (2002–2019)
por: Yang, Aimin, et al.
Publicado: (2022)

The role of age on the risk relationship between prediabetes and major morbidities and mortality: Analysis of the Hong Kong diabetes surveillance database of 2 million Chinese adults
por: Zhang, Xinge, et al.
Publicado: (2022)

Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: A prospective cohort study
por: Yang, Aimin, et al.
Publicado: (2022)

The impact of automated eGFR reporting and education on nephrology service referrals
por: Noble, Euan, et al.
Publicado: (2008)

Risk associations of long-term HbA1c variability and obesity on cancer events and cancer-specific death in 15,286 patients with diabetes - A prospective cohort study
por: Mao, Dandan, et al.
Publicado: (2021)

Risk Associations of Glycemic Burden and Obesity With Liver Cancer—A 10‐Year Analysis of 15,280 Patients With Type 2 Diabetes
por: Mao, Dandan, et al.
Publicado: (2022)

Point of Care eGFR and the Prediction of Outcomes in Pneumonia
por: Suk, Chi-won, et al.
Publicado: (2019)

Impact of a single eGFR and eGFR-estimating equation on chronic kidney disease reclassification: a cohort study in primary care
por: Hirst, Jennifer A, et al.
Publicado: (2018)

Potential relationship between eGFR(cystatin C)/eGFR(creatinine)‐ratio and glomerular basement membrane thickness in diabetic kidney disease
por: Öberg, Carl M., et al.
Publicado: (2021)

Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populations
por: Eastwood, John B., et al.
Publicado: (2010)

International Collaboration for the Epidemiology of eGFR in Low and Middle Income Populations - Rationale and core protocol for the Disadvantaged Populations eGFR Epidemiology Study (DEGREE)
por: Caplin, Ben, et al.
Publicado: (2017)

Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: A population-based observational study
por: Ke, Calvin, et al.
Publicado: (2020)

Development and validation of algorithms to classify type 1 and 2 diabetes according to age at diagnosis using electronic health records
por: Ke, Calvin, et al.
Publicado: (2020)

Low HDL Cholesterol, Metformin Use, and Cancer Risk in Type 2 Diabetes: The Hong Kong Diabetes Registry
por: Yang, Xilin, et al.
Publicado: (2011)

Short‐Term Change in eGFR and Risk of Cardiovascular Events
por: Turin, Tanvir Chowdhury, et al.
Publicado: (2014)

Age and the eGFR-dependent risk for adverse clinical outcomes
por: Liu, Ping, et al.
Publicado: (2022)

Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR
por: Munch, Philip Vestergaard, et al.
Publicado: (2023)

eGFR(cystatinC)/eGFR(creatinine) ratio < 0.6 in patients with SARS-CoV-2 pneumonia: a prospective cohort study
por: Avotins, Lauris, et al.
Publicado: (2023)

Impaired selective renal filtration captured by eGFR(cysC)/eGFR(crea) ratio is associated with mortality in a population based cohort of older women
por: Malmgren, Linnea, et al.
Publicado: (2022)

Effects of RAS inhibitors on all-site cancers and mortality in the Hong Kong diabetes surveillance database (2002-2019)
por: Yang, Aimin, et al.
Publicado: (2022)

Associations of the HOMA2‐%B and HOMA2‐IR with progression to diabetes and glycaemic deterioration in young and middle‐aged Chinese
por: Fan, Baoqi, et al.
Publicado: (2022)

Renal quality outcomes framework and eGFR: impact on secondary care
por: Phillips, LA, et al.
Publicado: (2012)

Correlation analysis between eGFR(cys) and SXscore in patients with diabetes
por: YONG, ZHONG, et al.
Publicado: (2014)

Low eGFR is associated with dysexecutive and amnestic mild cognitive impairment
por: Zammit, Andrea R., et al.
Publicado: (2015)

Mendelian Randomisation study of the influence of eGFR on coronary heart disease
por: Charoen, Pimphen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8bgblnneroqbtf1uf9p7pkceqb